Position history for VIKING GLOBAL INVESTORS LP's holdings in ADAPTIVE BIOTECHNOLOGIES COR
VIKING GLOBAL INVESTORS LP holds 30M shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), worth $487.1M as of 2025-Q4. ADPT represents 1.3% of VIKING GLOBAL INVESTORS LP's portfolio.
Current Value
$487.1M
Current Shares
30M
Total Value Change
+$378.5M
Total Shares Change
0
Other major holders of ADPT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 30M |
0.0% |
| $487.1M |
| 1.3% |
| $16.42 |
0 |
| 2025-Q3 | Unchanged | 30M | 0.0% | $448.7M | 1.2% | $13.46 | 0 |
| 2025-Q2 | Unchanged | 30M | 0.0% | $349.4M | 1.0% | $11.79 | 0 |
| 2025-Q1 | Unchanged | 30M | 0.0% | $222.9M | 0.7% | $7.67 | 0 |
| 2024-Q4 | Unchanged | 30M | 0.0% | $179.8M | 0.6% | $6.11 | 0 |
| 2024-Q3 | Unchanged | 30M | 0.0% | $153.6M | 0.6% | $5.00 | 0 |
| 2024-Q2 | Unchanged | 30M | 0.0% | $108.6M | 0.4% | $3.62 | 0 |